Lanreotide

Chemical formula: C₅₄H₆₉N₁₁O₁₀S₂  Molecular mass: 1,096.33 g/mol  PubChem compound: 71349

Therapeutic indications

Lanreotide is indicated for:

Acromegaly

Population group: only adults (18 years old or older)

The treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or Insulin-like Growth Factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatment. The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalise these values.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroenteropancreatic neuroendocrine tumours (GEP-NETs)

Population group: only adults (18 years old or older)

The treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Neuroendocrine tumours

Population group: only adults (18 years old or older)

The treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumours.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Thyrotropic adenomas

Population group: only adults (18 years old or older)

Treatment of thyrotropic adenomas when the circulating level of thyroid stimulating hormone remains inappropriately high after surgery and/or radiotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Postoperative pancreatic fistula, postoperative small bowel fistula

Population group: only adults (18 years old or older)

at least one of
Pancreatic fistula
Small bowel fistula

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.